Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2287]
News [5258]
Articles [128]
Editorials [4]
Conferences [157]
elearning [13]
OncoAlert Colloquium Day 4: Gynae-oncology, lymphoma, sarcoma and melanoma
Dr Dizon, Dr Trent, Dr Cordoba, Dr Rolfo, Dr Haanen
OncoAlert Colloquium Day 4: Gynae-oncology, lymphoma, sarcoma and melanoma ( Dr Dizon, Dr Trent, Dr Cordoba, Dr Rolfo, Dr Haanen )
23 Dec 2020
OncoAlert Colloquium Day 5: Genitourinary tumours and social media
Dr McBride, Dr Apolo, Dr Choueiri, Dr Morgan, Dr Agarwal
OncoAlert Colloquium Day 5: Genitourinary tumours and social media ( Dr McBride, Dr Apolo, Dr Choueiri, Dr Morgan, Dr Agarwal )
23 Dec 2020
Results of venetoclax and azacitidine combination in chemotherapy ineligible...
Prof Hagop Kantarjian - MD Anderson Cancer Center, Houston, USA
Results of venetoclax and azacitidine combination in chemotherapy ineligible untreated patients with AML ( Prof Hagop Kantarjian - MD Anderson Cancer Center, Houston, USA )
22 Dec 2020
Long-term follow-up of low-intensity chemotherapy with combination therapy for...
Prof Hagop Kantarjian - MD Anderson Cancer Center, Houston, USA
Long-term follow-up of low-intensity chemotherapy with combination therapy for r/r Ph- acute lymphoblastic leukaemia patients ( Prof Hagop Kantarjian - MD Anderson Cancer Center, Houston, USA )
22 Dec 2020
Real-world evidence of the use of carfilzomib among multiple myeloma patients...
Prof Evangelos Terpos - University of Athens, Athens, Greece
Real-world evidence of the use of carfilzomib among multiple myeloma patients across 10 European countries and Israel ( Prof Evangelos Terpos - University of Athens, Athens, Greece )
22 Dec 2020
Real-world evidence of the use of carfilzomib to refractory to lenalidomide...
Prof Evangelos Terpos - University of Athens, Athens, Greece
Real-world evidence of the use of carfilzomib to refractory to lenalidomide patients ( Prof Evangelos Terpos - University of Athens, Athens, Greece )
22 Dec 2020
A treatment comparison of carfilzomib, dexamethasone and daratumumab to...
Prof Evangelos Terpos - University of Athens, Athens, Greece
A treatment comparison of carfilzomib, dexamethasone and daratumumab to daratumumab and bortezomib ( Prof Evangelos Terpos - University of Athens, Athens, Greece )
22 Dec 2020
2020 updates in treating NTRK fusion cancer
Dr Alexander Drilon and Prof Marc Peeters
2020 updates in treating NTRK fusion cancer ( Dr Alexander Drilon and Prof Marc Peeters )
22 Dec 2020
PARP inhibitors for prostate cancer: What oncology PAs should know
Colleen Tetzlaf, PA-C, Fox Chase Cancer Center, Philadelphia, USA
PARP inhibitors for prostate cancer: What oncology PAs should know ( Colleen Tetzlaf, PA-C, Fox Chase Cancer Center, Philadelphia, USA )
18 Dec 2020
ESMO 2020: New developments in the treatment of lung cancer
Dr Luis Raez - Memorial Cancer Institute, Miami, USA
ESMO 2020: New developments in the treatment of lung cancer ( Dr Luis Raez - Memorial Cancer Institute, Miami, USA )
17 Dec 2020
SABCS 2020: Conference roundup
Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy
SABCS 2020: Conference roundup ( Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy )
16 Dec 2020
ASH 2020: Immunotherapy in relapsed/refractory multiple myeloma
Dr Robert Rifkin, Prof Sagar Lonial, Prof Evangelos Terpos, Dr Nina Shah, Dr...
ASH 2020: Immunotherapy in relapsed/refractory multiple myeloma ( Dr Robert Rifkin, Prof Sagar Lonial, Prof Evangelos Terpos, Dr Nina Shah, Dr Eric Smith )
15 Dec 2020

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation